Latest News and Upcoming Events

Kirkstall Ltd Follow

Kirkstall's patented Quasi Vivo® technology is an advanced dynamic flow system that simulates physiology and is used to study drug toxicity and disease.

Kirkstall Ltd

@kirkstall_ltd ·

10 Sep

The Human Specific Research Community North launched at the University of Bradford last week — a regional network for researchers moving to human-specific methods, set up by Animal Free Research UK.

Kirkstall's Malcolm Wilkinson, a trustee of the charity, was there.

Reply on Twitter 2098005699884134809 Retweet on Twitter 2098005699884134809 2 Like on Twitter 2098005699884134809 3 Twitter 2098005699884134809

Kirkstall Ltd

@kirkstall_ltd ·

1 Sep

Kirkstall is named among the ten key companies in DelveInsight's Organ-on-Chip market report, which values the sector at $0.52bn in 2025 rising to $3.10bn by 2034, a 22% CAGR.

Quasi Vivo is cited in the liver-on-a-chip segment — the largest at 29%.

→

Reply on Twitter 2094782281164398813 Retweet on Twitter 2094782281164398813 1 Like on Twitter 2094782281164398813 4 Twitter 2094782281164398813

Kirkstall Ltd

@kirkstall_ltd ·

12 Jun

New in Biomaterials Advances: long-term dynamic flow using @Kirkstall_Ltd Quasi Vivo disrupted fibrotic stroma in pancreatic cancer models and reduced chemotherapy resistance — results static culture missed.
→ http://sciencedirect.com/science/article/pii/S2772950826002827
#PDAC #OrganOnAChip

Reply on Twitter 2065377066883629119 Retweet on Twitter 2065377066883629119 Like on Twitter 2065377066883629119 1 Twitter 2065377066883629119

Quasi Vivo®, used in 100+ labs worldwide, getting started is easy and cost-effective!

Enquire Now

Sign Up For Our Newsletter

For all the latest from us, including interesting research videos and more, please subscribe to our newsletter below.
All data is stored in accordance with our privacy policy .

Phone: + 44 (0) 1709 361 241

Business Hours: Monday to Friday 9:00am-5:00pm (UK Time)